-transparent.png){kind=logo}
To determine whether immunosuppression would result in retrovirus expression in previously infected rhesus monkeys, chronic high dose methyl prednisolone therapy was administered to two groups of animals for 4 weeks. One group was antibody positive for a type D retrovirus, designated Type D/3/wisc. The second group of animals had no known exposure to Type D/3/wisc and was antibody negative to this virus. The monkeys were evaluated for immunosuppression and retrovirus re-expression following the corticosteroid therapy. Although this treatment induced a marked cellular immunosuppression in all animals, as measured by in vitro assays, in none of the animals was retrovirus viremia or retrovirus-associated disease detected.
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
November 1984,
Journal of virology,
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
February 1991,
The Journal of general virology,
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
January 1990,
Journal of medical primatology,
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
April 1991,
Laboratory animal science,
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
January 1998,
Neurobiology of aging,
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
October 1987,
Journal of the National Cancer Institute,
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
October 2003,
Virology,
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
May 2006,
Transplant international : official journal of the European Society for Organ Transplantation,
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
April 1986,
Neurology,
K T Schultz, and
S Gravenstein, and
T Curro, and
C Thomas, and
W B Ershler
January 1991,
American journal of primatology,
